| Literature DB >> 35576744 |
Mahdi Vasighi1, Julia Romanova2, Miroslava Nedyalkova3.
Abstract
The COVID-19 has a worldwide spread, which has prompted concerted efforts to find successful drug treatments. Drug design focused on finding antiviral therapeutic agents from plant-derived compounds which may disrupt the attachment of SARS-CoV-2 to host cells is with a pivotal need and role in the last year. Herein, we provide an approach based on drug design methods combined with machine learning approaches to classify and discover inhibitors for COVID-19 from natural products. The spike receptor-binding domain (RBD) was docked with database of 125 ligands. The docking protocol based on several steps was performed within Autodock Vina to identify the high-affinity binding mode and to reveal more insights into interaction between the phytochemicals and the RBD domain. A protein-ligand interaction analyzer has been developed. The drug-likeness properties of explored inhibitors are analyzed in the frame of exploratory data analyses. The developed computational protocol yielded a comprehensive pipeline for predicting the inhibitors to prevent the entry RBD region.Entities:
Keywords: Cluster analyses; Computer-aided drug design; DFT; Docking; Principal component analysis
Mesh:
Substances:
Year: 2022 PMID: 35576744 PMCID: PMC9090871 DOI: 10.1016/j.compbiolchem.2022.107694
Source DB: PubMed Journal: Comput Biol Chem ISSN: 1476-9271 Impact factor: 3.737
The eigenvalues, percent of explained variances, and the cumulative explained variances by the first 10 PCs for the studied dataset.
| PC No. | Eigenvalue | Explained Variance | Cumulative Explained Variance |
|---|---|---|---|
| 1 | 1.006 | 37.898 | 37.898 |
| 2 | 0.494 | 18.608 | 56.506 |
| 3 | 0.284 | 10.708 | 67.214 |
| 4 | 0.136 | 5.1543 | 72.368 |
| 5 | 0.122 | 4.6207 | 76.989 |
| 6 | 0.090 | 3.4027 | 80.391 |
| 7 | 0.070 | 2.6388 | 83.030 |
| 8 | 0.052 | 1.9705 | 85.001 |
| 9 | 0.043 | 1.6229 | 86.623 |
| 10 | 0.040 | 1.5367 | 88.160 |
K-means clustering result (K=10).
| Cluster id | Number of members | Members | Mean Docking Score |
|---|---|---|---|
| 1 | 13 | '1,8-Cineole', '4-Terpinyl acetate', 'Anethole', 'Artemisia ketone', 'Beta-Thujone','Camphor','Cis-anethole','Citronellyl acetate', 'Isopinocamphone', ' | -4.8923 |
| 2 | 23 | '7-Methoxycryptopleurine', 'Alpha-Bisabolol', 'Blancoxanthone', 'Broussochalcone b′, 'Camazulene', 'Curcumin', 'Demethoxycurcumin', 'Dihydrotanshinone', 'Dihydrotanshinone', 'Guaiol', 'Isobavachalcone', 'Methyl tanshinonate', 'Monodemethylcurcumin', 'Neobavaisoflavone', 'Psoralidin', 'Pyranojacareubin', 'Spathulenol', 'Tanshinone i′, 'Tanshinone iia', 'Tanshinone IIb', 'Tau-Cadinol', 'Tetrahydrocurcumin', 'Viridiflorol' | -7.1783 |
| 3 | 12 | '6-Oxoisoiguesterin', 'Beta-Sitosterol', 'Betulinic acid', 'Celastrol', 'Epitaraxerol', 'Friedelin', 'Iguesterin', 'Pristimerin', 'Quadrangularic acid f′, 'Sanggenol E′, 'Schimperinone', 'Smilagenin' | -8.1083 |
| 4 | 7 | 'Amentoflavone', 'Artocommunol e′, 'Jubanine G′, 'Jubanine H′, 'Nummularine B′, 'Ouabain', 'Silvestrol' | -7.4857 |
| 5 | 1 | 'Dehydroabieta-7-one' | -7.3000 |
| 6 | 19 | '( | -6.7789 |
| 7 | 16 | '(+)-artemisinic alcohol', '1-Cyclopentyl-2-propen-1-ol', 'Alpha-pinene', 'Artemisia alcohol', 'Ascaridole', 'Beta-pinene', 'Camphene','Carvacrol', 'Caryophyllene oxide', 'Eugenol', 'Limonene', 'Linalool', 'Myrcene', 'Sabinene', 'Terpinen-4-ol', 'Thujene' | -5.0875 |
| 8 | 8 | 'Epigallocatechin gallate', 'Gallocatechin gallate', 'Myricetin 3-(4''-Galloylrhamnoside)', 'Myricetin 3-Neohesperidoside', 'Myricetin 3-Sambubioside', 'Myricetin 3''-Rhamnoside', 'Pectolinarin', 'Rhoifolin' | -7.9000 |
| 9 | 5 | 'Akebia saponin c′, 'Ardisia Saponin', 'Glycyrrhizin', 'Ursane', 'Saikosaponin B2' | -8.4600 |
| 10 | 21 | '3-Friedelanol', 'Ampelopsin', 'APA', 'Apigenin', 'Baicalein', 'Biochanin a′, 'Chrysin', 'Emodin', 'Fisetin', 'Formononetin', 'Gallic acid', 'Genistein', 'Hesperetin', 'Isoliquiritigenin', 'Kaempferol', 'Luteolin', 'Quercetin', 'Rhein', 'Sappanchalcone', 'Scutellarein', 'Taxifolin' | -7.0190 |
Fig. 1The RBD with the top 3 ligands: Smilagenin, 10'-hydroxyusambarensine, and Celastrol.
Fig. 2Hydrophobic pocket for the RBD pointed with the cycle for the receptor. Represented with Gaussian hydrophobic surface. The red-blue color scheme, red – hydrophobic, blue–hydrophilic.
Fig. 3(a) the 3D structure of Smilagenin (b) RBD with Smilagenin as a ligand in the active binding site pocket view represented in Gaussian hydrophobic surface. The red-blue color scheme, red – hydrophobic, blue – hydrophilic(c) the 3D structure of 10'-hydroxyusambarensine (d) RBD with 10'-hydroxyusambarensine as a ligand in the active binding site pocket (e) the 3D structure of Celastrol (f) RBD with Celastrol as a ligand in the active binding site.
Fig. 4Score plots resulted from PCA analysis labeled with row numbers (molecules) (a) PC1 vs. PC2 (b) PC2 vs. PC1 (c) three-dimensional score plot (PC1 vs. PC2 vs. PC3.
Fig. 5Loading values of the descriptors for the first three PCs.
Fig. 6(a) 2D Loading plot (PC1 vs. PC2) reveals the contribution of descriptors to define PCs directions. (b) 3D loading plot (PC1 vs. PC2 vs PC3).
Fig. 7Calinski-Harabasz criterion values for different number of clusters (k).
Fig. 8(a) The result of K-means clustering is shown with the 3D score plot (PC1 vs. PC2 vs PC3). Molecular clusters are specified by color and numbers. (b) 3D Score plot including docking score information coded with color and size of the marker. Small blue-colored points are the compounds with lower binding affinity and the red ones (bigger marker size) are the molecules with the highest obtained binding affinity.
Fig. 9MLR coefficients for the selected molecular descriptors.
Fig. 10scatterplot of calculated docking score vs. the experimental docking score value obtained by AutoDoc Vina, demonstrating the good prediction accuracy achieved by variable selection and MLR model.